TIDMSBS

RNS Number : 1995J

Source BioScience PLC

07 September 2016

7 September 2016

Source BioScience plc

(or "the Company")

Rule 2.10 - Number of Relevant Securities in Issue

Pursuant to Rule 2.10 of the Code, Source BioScience confirms that there are 349,351,081 ordinary shares of 2 pence each in issue with International Securities Identification Number GB0009739649.

Enquiries

Source BioScience plc

Dr Nick Ash, Company Secretary

Tel: +44 (0) 115 973 9010

Email: enquiries@sourcebioscience.com

www.sourcebioscience.com

About Source BioScience:

Source BioScience plc (LSE: SBS) is a trusted provider of state of the art Laboratory Services and Products to the healthcare and clinical, life and applied sciences and biopharma industries. It is an international business operating ten state of the art facilities in five countries and with customers in over 90 countries worldwide. The Group offers a complementary portfolio of Laboratory Services and Products that share common technologies, laboratory processes, infrastructure and expertise. These include Diagnostics, DNA Sequencing and Genomics, Analytical and Regulated Services, Clinical Products, Life Science Research Reagents and Controlled Environment for a comprehensive range of applications. These Laboratory Services and Products are provided to a large and diverse customer base including the top 50 pharmaceutical companies, leading universities and research institutes worldwide, the UK NHS and other healthcare providers. The Group is listed on the Premium Main Market of the London Stock Exchange.

This information is provided by RNS

The company news service from the London Stock Exchange

END

RTTEANNXESAKEEF

(END) Dow Jones Newswires

September 07, 2016 05:55 ET (09:55 GMT)

Source Bioscience (LSE:SBS)
Gráfica de Acción Histórica
De Abr 2024 a May 2024 Haga Click aquí para más Gráficas Source Bioscience.
Source Bioscience (LSE:SBS)
Gráfica de Acción Histórica
De May 2023 a May 2024 Haga Click aquí para más Gráficas Source Bioscience.